Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Insights - The company reported better-than-expected performance in Q3, with a revenue decline of 4.29% compared to a 30% decline in Q2, indicating a potential operational turnaround [6] - The company is focusing on health-oriented products and plans to enhance its market presence with clean ingredient labels and organic offerings [6] - The report suggests that the current year represents the operational bottom for the company, with a recommendation to actively monitor future revenue performance [6] Financial Data and Earnings Forecast - Total revenue for 2025 is estimated at 2,806 million, with a year-on-year decline of 8.7% [5] - The net profit attributable to the parent company for 2025 is projected to be 406 million, reflecting a year-on-year decrease of 20.9% [5] - The company’s gross margin for Q3 was 39%, an increase of 1.5 percentage points year-on-year, primarily due to cost reductions [6] - The report forecasts a recovery in revenue growth for 2026 and 2027, with net profits expected to rise to 508 million and 610 million, respectively [6][5]